ZALEPLON
NDC 57237-239, ZALEPLON, capsule, from Rising Pharma Holdings, Inc..
- Product NDC
- 57237-239
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078829
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/57237-239 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZALEPLON5 mg/1
Pharmacologic classes
Central Nervous System Depression [PE]; GABA A Agonists [MoA]; gamma-Aminobutyric Acid A Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57237-239-01 | 57237023901 | 100 CAPSULE in 1 BOTTLE (57237-239-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cff46def-c452-49bb-abea-480de8f432bdNADAC price for package 57237023901
GET /v1/drugs/nadac/57237023901
Use it
Look up 57237-239 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57237-239 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57237-239. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.